In prostate cancer, many genes from the ETS family participate in fusion transcripts with transmembrane serine protease isoform 2 (TMPRSS2); in fact, three ETS members (ERG, ETV1, and ETV4) contribute to about 80% of TMPRSS2 fusion [41, 42]. Here, ETV4 is linked to prostate carcinoma.